Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05749445
What this trial is testing

Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients

Who this might be right for
Hospitalized Patients
First People's Hospital of Hangzhou 200
Post-approval studies (Phase 4)Study completedNCT00641082
What this trial is testing

Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

Who this might be right for
HBeAg(-) Chronic Hepatitis B With Compensated Liver Function
Bukwang Pharmaceutical 43
Testing effectiveness (Phase 2)Study completedNCT01022801
What this trial is testing

A Phase II Dose Response Study in Japan in Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 120
Early research (Phase 1)Study completedNCT06385327
What this trial is testing

Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 115
Testing effectiveness (Phase 2)Looking for participantsNCT07406217
What this trial is testing

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients

Who this might be right for
COVID-19Immunodeficiency
Calmy Alexandra 256
Not applicableStudy completedNCT01457755
What this trial is testing

Gilead Sustained Virologic Response (SVR) Registry

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 6,625
Not applicableUnknownNCT05376943
What this trial is testing

Possible Differences in HCC Course Depending on DAA Treatment

Who this might be right for
Carcinoma, HepatocellularHepatitis C Virus Infection, Response to Therapy ofDrug Effect+3 more
Medical University of Warsaw 100
Testing effectiveness (Phase 2)Looking for participantsNCT05648448
What this trial is testing

Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Who this might be right for
InfluenzaInfluenza, Human
University of Oxford 3,000
Post-approval studies (Phase 4)Study completedNCT01488526
What this trial is testing

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Who this might be right for
Hepatitis B InfectionChronic InfectionViremia
New Discovery LLC 200
Not applicableStudy completedNCT06668025
What this trial is testing

MxA-Guided Antiviral Treatment in Respiratory Viral Infections

Who this might be right for
Respiratory Viral InfectionsInfluenzaSARS CoV-2
Capital Medical University 86
Testing effectiveness (Phase 2)Study completedNCT04425252
What this trial is testing

Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19

Who this might be right for
COVID-19
Clear Creek Bio, Inc. 25
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Large-scale testing (Phase 3)Study completedNCT01979939
What this trial is testing

UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 416
Early research (Phase 1)Ended earlyNCT07115368
What this trial is testing

Study of GS-1219 in Participants With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06993480
What this trial is testing

Evaluate the Antiviral Activity and Immune Response of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B
Ausper Biopharma Co., Ltd. 20
Early research (Phase 1)UnknownNCT05234320
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug

Who this might be right for
Healthy
Caregen Co. Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT01438424
What this trial is testing

Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials

Who this might be right for
Hepatitis B VirusHBV
Bristol-Myers Squibb 1,053
Not applicableLooking for participantsNCT02647879
What this trial is testing

Treatment as Prevention for Hepatitis C in Iceland

Who this might be right for
Hepatitis C
Landspitali University Hospital 1,000
Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT00000820
What this trial is testing

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 104
Next Page